Long-Term Azithromycin Maintenance Treatment in Patients with Frequent Exacerbations of Chronic Obstructive Pulmonary Disease.


Journal

International journal of chronic obstructive pulmonary disease
ISSN: 1178-2005
Titre abrégé: Int J Chron Obstruct Pulmon Dis
Pays: New Zealand
ID NLM: 101273481

Informations de publication

Date de publication:
Historique:
received: 07 10 2020
accepted: 07 01 2021
entrez: 10 3 2021
pubmed: 11 3 2021
medline: 29 6 2021
Statut: epublish

Résumé

Macrolides are effective in reducing the number of exacerbations in COPD patients with the frequent exacerbator phenotype. Our study did not show a persistent effect of azithromycin on exacerbation frequencies after more than one year of usage.

Identifiants

pubmed: 33688175
doi: 10.2147/COPD.S284397
pii: 284397
pmc: PMC7935328
doi:

Substances chimiques

Anti-Bacterial Agents 0
Macrolides 0
Azithromycin 83905-01-5

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

495-498

Informations de copyright

© 2021 Talman et al.

Déclaration de conflit d'intérêts

Prof. Dr. Joachim Aerts reports personal fees and/or grants from BMS, MSD, Boehringer Ingelheim, Astra-Zeneca, Eli-Lilly, Amphera, Roche, and Bayer, outside the submitted work; In addition, Prof. Dr. Joachim Aerts has a patent tumor cell lysate licensed to Amphera, a patent biomarker for immunotherapy. The authors report no other conflicts of interest in this work.

Références

Lancet. 2014 Aug 23;384(9944):691-702
pubmed: 25152271
Lancet Respir Med. 2014 May;2(5):361-8
pubmed: 24746000
J Cyst Fibros. 2015 May;14(3):293-304
pubmed: 25881770
Lancet Respir Med. 2013 May;1(3):262-74
pubmed: 24429132
N Engl J Med. 2012 May 17;366(20):1881-90
pubmed: 22591294
Chest. 2018 May;153(5):1125-1133
pubmed: 29427576
Thorax. 2004 May;59(5):387-95
pubmed: 15115864
ERJ Open Res. 2018 May 04;4(2):
pubmed: 29750142
Am J Respir Crit Care Med. 2015 Oct 15;192(8):943-50
pubmed: 26151174
Respir Med. 2016 Aug;117:1-6
pubmed: 27492507
Am J Respir Crit Care Med. 2008 Dec 1;178(11):1139-47
pubmed: 18723437
N Engl J Med. 2011 Aug 25;365(8):689-98
pubmed: 21864166

Auteurs

Sander Talman (S)

Amphia Hospital Breda, Department of Pulmonary Medicine, Breda, 4800RK, the Netherlands.

Sevim Uzun (S)

Erasmus Medical Centre Rotterdam, Department of Pulmonary Medicine, Rotterdam, 3015 CE, the Netherlands.

Remco S Djamin (RS)

Amphia Hospital Breda, Department of Pulmonary Medicine, Breda, 4800RK, the Netherlands.

Sara J Baart (SJ)

Erasmuc Medical Centre Rotterdam, Department of Biostatistics, Rotterdam, 3015 CE, the Netherlands.

Marco J J H Grootenboers (MJJH)

Amphia Hospital Breda, Department of Pulmonary Medicine, Breda, 4800RK, the Netherlands.

Joachim Aerts (J)

Erasmus Medical Centre Rotterdam, Department of Pulmonary Medicine, Rotterdam, 3015 CE, the Netherlands.

Menno van der Eerden (M)

Erasmus Medical Centre Rotterdam, Department of Pulmonary Medicine, Rotterdam, 3015 CE, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH